Role of B Cell Profile for Predicting Secondary Autoimmunity in Patients Treated With Alemtuzumab

OBJECTIVE: To explore if baseline blood lymphocyte profile could identify relapsing remitting multiple sclerosis (RRMS) patients at higher risk of developing secondary autoimmune adverse events (AIAEs) after alemtuzumab treatment. METHODS: Multicenter prospective study including 57 RRMS patients tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Walo-Delgado, Paulette Esperanza, Monreal, Enric, Medina, Silvia, Quintana, Ester, Sainz de la Maza, Susana, Fernández-Velasco, José Ignacio, Lapuente, Paloma, Comabella, Manuel, Ramió-Torrentà, Lluis, Montalban, Xavier, Midaglia, Luciana, Villarrubia, Noelia, Carrasco-Sayalero, Angela, Rodríguez-Martín, Eulalia, Roldán, Ernesto, Meca-Lallana, José, Alvarez-Lafuente, Roberto, Masjuan, Jaime, Costa-Frossard, Lucienne, Villar, Luisa Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531491/
https://www.ncbi.nlm.nih.gov/pubmed/34691084
http://dx.doi.org/10.3389/fimmu.2021.760546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531491/
https://www.ncbi.nlm.nih.gov/pubmed/34691084
http://dx.doi.org/10.3389/fimmu.2021.760546

Ejemplares similares